Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank64
3Y CAGR-10.8%
5Y CAGR-4.7%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-10.8%/yr
vs -5.3%/yr prior
5Y CAGR
-4.7%/yr
Recent deceleration
Acceleration
-5.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.92% | +4.2% |
| 2024 | 3.77% | -0.2% |
| 2023 | 3.77% | -31.8% |
| 2022 | 5.53% | -24.4% |
| 2021 | 7.31% | +46.4% |
| 2020 | 4.99% | -48.8% |
| 2019 | 9.76% | +42.0% |
| 2018 | 6.87% | +132.8% |
| 2017 | 2.95% | +30.2% |
| 2016 | 2.27% | - |